The autoimmune disease testing market size was USD 4.84 billion in 2021 and is projected to grow from USD 5.52 billion in 2022 to USD 10.75 billion by 2029, exhibiting a CAGR of 10.0%. Based on our analysis, the global market exhibited a decline of -7.1% in 2020 as compared to 2019.
